Off-white to pale yellow crystalline powder with a molecular weight of 427.48 g mol⁻¹, corresponding to the empirical formula C₂₁H₂₀N₃O₅S. The compound is synthesized via a Z-configuration oxime ether linkage at the 2-position of the thiazole ring, with the diphenylmethoxy group serving as a transient protecting group for the pendant carboxylic acid during cephalosporin core construction. Commercial lots are assayed by non-aqueous titration against perchloric acid and consistently ship with a purity floor of 98.5% (area normalization, HPLC, 230 nm). Water content, determined by Karl Fischer coulometry per USP <921> Method Ic, is held below 0.3% w/w to prevent premature oxime hydrolysis during storage. This intermediate is primarily consumed in the acylation step of 7-aminocephalosporanic acid (7-ACA) to produce third-generation β-lactam antibiotics, where the intact diphenylmethoxy ester ensures regioselective ring opening.
Thermal Degradation Pathways During Vacuum Drying
Differential scanning calorimetry under nitrogen purge at 10 K min⁻¹ reveals an endothermic melt onset at 142–145°C with immediate exothermic decomposition exceeding 150 J g⁻¹. The primary degradants identified by LC-MS are the free carboxylic acid (cleaved ester) and the corresponding 2-aminothiazole oxime. Drying protocols on rotary evaporators coupled to oil-sealed rotary vane pumps (<1 mbar) must maintain jacket temperatures below 40°C. Batch records from kilogram-scale campaigns indicate that a temperature excursion to 55°C for 4 hours reduces assay by 1.8–2.2% absolute, with the des-ester impurity crossing the 1.0% ICH Q3A qualification threshold. Plant-scale conical dryers with heated nitrogen sweep at 35°C and 0.2 bar(g) demonstrate stable assay over 48-hour cycles.
Moisture sensitivity data collected under controlled relative humidity (RH) conditions show the product remains free-flowing at 30% RH and 25°C for 72 hours. In contrast, exposure to 75% RH yields visible lumping within 6 hours and a loss-on-drying shift of 1.5% accompanied by a crystalline-to-amorphous halo in powder X-ray diffraction. Secondary containment with molecular sieve sachets (3 Å, activated at 250°C) inside double LDPE liners inside fiber drums has been qualified for trans-Pacific ocean freight without cold chain, provided the container headspace is purged with dry argon to an oxygen level below 5,000 ppm.
What Limits Direct Use in Aqueous Coupling Media?
Solubility in water at 25°C is below 0.05 mg mL⁻¹ in the pH range 4–8. The compound dissolves readily in dimethylformamide (>200 mg mL⁻¹), N-methyl-2-pyrrolidone (>180 mg mL⁻¹), and dichloromethane (>100 mg mL⁻¹). Attempts to deprotonate the carboxylic acid moiety with aqueous sodium bicarbonate to enhance water solubility lead to competing β-elimination at the oxime linkage, generating 2-(2-aminothiazol-4-yl)-2-oxoacetic acid as a critical impurity. Process development reports across multiple pilot facilities converge on a single preferred activation route: pre-formation of the mixed anhydride with pivaloyl chloride in dry dichloromethane at −15 to −10°C, using 1.05 molar equivalents of N-methylmorpholine. Above 0°C, the mixed anhydride disproportionates to the symmetrical anhydride within 30 minutes, causing diketopiperazine formation upon subsequent coupling to 7-ACA.
Spectroscopic Fingerprints and Lot-to-Lot Confirmation
Infrared spectra (KBr pellet) are dominated by the ester carbonyl stretch at 1728 ± 2 cm⁻¹, the oxime C=N stretch at 1635 cm⁻¹, and the thiazole ring breathing mode at 1530 cm⁻¹. Discrepancies in the intensity ratio of the 1728 cm⁻¹ to 1635 cm⁻¹ bands exceeding 10% relative standard deviation across five pellets signal partial ester hydrolysis. Proton NMR in DMSO-d₆ (400 MHz) exhibits the characteristic methine proton of the diphenylmethyl group as a singlet at δ 6.80, integrating for one proton against the thiazole aromatic singlet at δ 6.95. The Z-oxime geometry is confirmed by the absence of an NOE cross-peak between the methoxyimino methyl protons (δ 3.85) and the thiazole proton, whereas the E-isomer, a known minor contaminant from the oximation step, shows a clear through-space correlation. Required lot-release documentation includes a scanned ¹H NMR spectrum with integration table, an HPLC chromatogram with peak purity analysis, and a residual solvents report per USP <467> verifying dichloromethane below 600 ppm and DMF below 880 ppm.
| Parameter | Present Compound | 2-Aminothiazole-4-acetic acid ethyl ester | (Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetic acid (ATMA) |
|---|---|---|---|
| Molecular weight | 427.48 g mol⁻¹ | 186.23 g mol⁻¹ | 201.20 g mol⁻¹ |
| Ester protecting group | Diphenylmethyl (DPM) | Ethyl | None (free acid) |
| Acid-labile cleavage half-life (25°C, 4M HCl/dioxane) | 2–3 min | >12 h | N/A |
| Typical purity (HPLC, 230 nm) | ≥98.5% | ≥95.0% | ≥99.0% |
| Primary application stage | Acylation of 7-ACA/DAC | Early intermediate, ring construction | Active pharmaceutical ingredient precursor |
| Storage condition | 2–8°C, argon blanket | 2–8°C, ambient | −20°C, desiccated |
Selecting between the diphenylmethyl-protected compound and ATMA is a decision driven by downstream coupling chemistry. ATMA eliminates the deprotection step but requires activation as the benzothiazolyl thioester (MAEM) or the 2-mercaptobenzothiazole active ester, which introduces a low-yield crystallization and additional genotoxic impurity scrutiny per ICH M7. The present compound permits direct mixed anhydride formation without mercaptan reagents, aligning with a cleaner impurity profile for cephalosporins susceptible to dimerization. In one published comparison using 7-amino-3-vinylcephalosporanic acid as the nucleus, the DPM-protected route achieved a weighted throughput yield of 78% over two steps (acylation plus TFA/anisole deprotection), versus 64% for the MAEM-mediated route. The penalty is the requirement for a strong acid deprotection cocktail—usually trifluoroacetic acid with 5–10% v/v anisole as a carbocation scavenger—necessitating Hastelloy C-22 reactors and dedicated acidic waste neutralization systems.
An additional differentiator emerges during scale-up of the acylation in non-participating solvents. The DPM ester imparts sufficient lipophilicity that the mixed anhydride remains in solution in dichloromethane at −10°C at 0.8 M concentration without precipitation, whereas ATMA-derived active esters frequently crystallize as solvates at concentrations above 0.4 M, fouling glass-lined reactor jackets. Reaction calorimetry data from a 200 L campaign show the pivaloyl chloride addition exotherm is controlled at −17 ± 3°C with jacket brine at −25°C, delivering a heat release rate below 15 W kg⁻¹. Failure to pre-chill the 7-ACA slurry to −10°C before mixed anhydride transfer results in a measurable exotherm overshoot to +2°C, at which point the side product 2,5-diketopiperazine derivative exceeds 3.5% peak area in the quenched reaction aliquot.
When Residual Palladium Carries Over from the Oximation Step
The synthesis of the oxime ether intermediate typically employs a palladium-catalyzed coupling of a 2-halo thiazole with a protected oxime donor. Residual palladium above 50 ppm in the technical grade product catalyses debenzylation of the diphenylmethyl group during the acidic deprotection of the final cephalosporin nucleus, leading to a cascade of benzhydryl cation adducts with the β-lactam ring. Manufacturers supplying this intermediate for GMP intermediate use include a dedicated charcoal treatment followed by filtration through a 0.45 μm polypropylene depth filter and a silica-metal scavenger plug. Inductively coupled plasma mass spectrometry specifications at release require Pd ≤ 10 ppm, Fe ≤ 20 ppm, Ni ≤ 5 ppm, and total heavy metals per Ph. Eur. 2.4.8 Method C below 20 ppm. A single batch rejected for 38 ppm palladium yielded a final active pharmaceutical ingredient with a distinct purple discoloration upon lyophilization and a 0.9% impurity identified as the DPM-adduct by LC-QTOF.
Process analytical technology implementations at contract manufacturing sites now employ in-line Raman spectroscopy during the final anti-solvent crystallization from acetonitrile/water. The polymorphic Form A, which exhibits better filtration kinetics on a centrifuge with 25 μm polypropylene cloth, is distinguished from the slower-filtering Form B by a peak shift at 1005 cm⁻¹. Seeding with 0.5% w/w micronized Form A crystals at 42°C during the cooling ramp reliably suppresses Form B nucleation. Particle size distribution after jet-milling is controlled to D₉₀ ≤ 50 μm and D₁₀ ≥ 5 μm, measured by laser diffraction on a dry dispersion unit at 1.5 bar. This specification ensures consistent dissolution in the reactor solvent within 15 minutes, avoiding unreacted solids that act as nucleation sites for by-product precipitation later in the synthesis.
| Condition | Duration | Assay (% initial) | Total impurities (% area) | Observations |
|---|---|---|---|---|
| 40°C / 75% RH, open dish | 4 weeks | 87.2 | 12.8 | Deliquescence, des-ester as major deg |
| 40°C / 75% RH, double LDPE bag | 12 weeks | 98.1 | 1.9 | No visible change |
| 25°C / 60% RH, amber glass, closed | 24 weeks | 99.0 | 0.8 | Stable |
| Photostability, ICH Q1B Option 2 (visible + UV, 1.2 million lux·h / 200 W·h·m⁻²) | — | 96.5 | 3.1 | Minor E-isomer increase, protect from light |
| Oxidative, 3% H₂O₂ solution in DMF, 25°C | 24 h | 72.4 | 27.6 | Sulfoxide and sulfone identified |
The oxidative sensitivity necessitates exclusion of peroxidizable solvents such as tetrahydrofuran and diethyl ether from final purification steps. Procurement specifications for dichloromethane require a peroxide content below 0.5 mg L⁻¹, measured by titanium sulfate colorimetry, and the solvent must be stabilized with amylene rather than ethanol to avoid transesterification. In multi-purpose plants, dedicated glass-lined equipment previously exposed to strong oxidizing agents must undergo a validated clean-out using 5% w/v sodium metabisulfite solution at 60°C for 2 hours followed by rinsing with water for injection to a conductivity endpoint of <2 μS cm⁻¹.
Resupply of this intermediate into clinical-phase projects commonly involves a technology transfer package that includes the differential scanning calorimetry trace, the HPLC method transfer protocol with two potential columns (C18, 250 × 4.6 mm, 5 μm, with either a stationary phase of endcapped octadecylsilane or a polar-embedded alkyl phase), and a forced degradation chromatogram establishing relative retention times for the des-ester, E-isomer, and dimeric impurities. The compound is classified as a Category 3 pharmaceutical intermediate under ICH Q7, with an assigned retest date of 24 months when continuously stored at 2–8°C in unopened argon-purged containers. Vendors shipping the material for GMP starting material applications provide a full downstream fate-and-purge statement for the diphenylmethyl group, along with a nitrosamine risk assessment per EMA/409815/2020 covering the oximation reagents.
In contrast to the structurally related 4-thiazoleacetic acid derivatives employed in monomeric β-lactam synthesis, this intermediate finds its niche in semi-synthetic cephalosporin routes where the diphenylhydromethyl ester can be chemoselectively removed in the presence of a β-lactam ring and a vinyl side chain at the 3-position. Published data for direct engagement of this compound in continuous flow platforms is limited; however, the mixed anhydride generation has been adapted to a Corning Advanced-Flow G1 reactor with a residence time of 90 seconds at −5°C, delivering 93% conversion before a subsequent packed-bed column of immobilized 7-ACA derivative. The key engineering challenge remains the low solubility of the pivalate salt by-product in dichloromethane at low temperatures, which clogs microchannel plates unless a periodic backflush with warm DMF is programmed every 40 cycles.
